Incidence and outcome of second malignancies in patients with chronic myeloid leukemia during treatment with tyrosine kinase inhibitors.
Nakazato T, Iriyama N, Tokuhira M, Ishikawa M, Sato E, Takaku T, Sugimoto KJ, Fujita H, Fujioka I, Kimura Y, Aisa Y, Iwanaga E, Asou N, Kizaki M, Hatta Y, Komatsu N, Kawaguchi T.
Nakazato T, et al. Among authors: kimura y.
Med Oncol. 2018 May 30;35(7):99. doi: 10.1007/s12032-018-1159-7.
Med Oncol. 2018.
PMID: 29846829